227 related articles for article (PubMed ID: 9017034)
1. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control.
Henricsson M; Nilsson A; Groop L; Heijl A; Janzon L
Acta Ophthalmol Scand; 1996 Dec; 74(6):523-7. PubMed ID: 9017034
[TBL] [Abstract][Full Text] [Related]
2. Ophthalmic health care in diabetes mellitus: a cross-sectional study in northern Sweden.
Reuterving CO; Kratholm J; Wachtmeister L
Ophthalmic Epidemiol; 1999 Dec; 6(4):267-78. PubMed ID: 10544341
[TBL] [Abstract][Full Text] [Related]
3. Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?
Wang Q; Dills DG; Klein R; Klein BE; Moss SE
Diabetes; 1995 Feb; 44(2):161-4. PubMed ID: 7859935
[TBL] [Abstract][Full Text] [Related]
4. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus.
Klein R; Klein BE; Moss SE
Ann Intern Med; 1996 Jan; 124(1 Pt 2):90-6. PubMed ID: 8554220
[TBL] [Abstract][Full Text] [Related]
5. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.
Klein R; Klein BE; Moss SE; Cruickshanks KJ
Ophthalmology; 1995 Jan; 102(1):7-16. PubMed ID: 7831044
[TBL] [Abstract][Full Text] [Related]
6. Serum Lipids and Proliferative Diabetic Retinopathy and Macular Edema in Persons With Long-term Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Klein BE; Myers CE; Howard KP; Klein R
JAMA Ophthalmol; 2015 May; 133(5):503-10. PubMed ID: 25502808
[TBL] [Abstract][Full Text] [Related]
7. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
Klein R; Myers CE; Lee KE; Paterson AD; Cruickshanks KJ; Tsai MY; Gangnon RE; Klein BE
JAMA Ophthalmol; 2015 Sep; 133(9):1054-61. PubMed ID: 26181138
[TBL] [Abstract][Full Text] [Related]
8. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR).
Hirai FE; Moss SE; Klein BE; Klein R
Diabetes Care; 2008 Mar; 31(3):493-7. PubMed ID: 18025409
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes.
Kullberg CE; Abrahamsson M; Arnqvist HJ; Finnström K; Ludvigsson J;
Diabet Med; 2002 Nov; 19(11):924-31. PubMed ID: 12421429
[TBL] [Abstract][Full Text] [Related]
10. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.
Klein R; Klein BE; Moss SE; Davis MD; DeMets DL
Arch Ophthalmol; 1984 Apr; 102(4):520-6. PubMed ID: 6367724
[TBL] [Abstract][Full Text] [Related]
11. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.
Klein R; Klein BE; Moss SE; Davis MD; DeMets DL
Arch Ophthalmol; 1984 Apr; 102(4):527-32. PubMed ID: 6367725
[TBL] [Abstract][Full Text] [Related]
12. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
Ozmen B; Boyvada S
J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
[TBL] [Abstract][Full Text] [Related]
13. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy.
Klein R; Klein BE; Moss SE
Diabetes; 1995 Jul; 44(7):796-801. PubMed ID: 7789648
[TBL] [Abstract][Full Text] [Related]
14. Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: The VISS Study.
Nordwall M; Fredriksson M; Ludvigsson J; Arnqvist HJ
Diabetes Care; 2019 Apr; 42(4):609-616. PubMed ID: 30705061
[TBL] [Abstract][Full Text] [Related]
15. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
[TBL] [Abstract][Full Text] [Related]
16. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.
Klein R; Klein BE; Moss SE; Cruickshanks KJ
Arch Intern Med; 1994 Oct; 154(19):2169-78. PubMed ID: 7944837
[TBL] [Abstract][Full Text] [Related]
17. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.
Klein R; Klein BE; Moss SE; Cruickshanks KJ
Ophthalmology; 1998 Oct; 105(10):1801-15. PubMed ID: 9787347
[TBL] [Abstract][Full Text] [Related]
18. [Diabetic retinopathy epidemiology in type II diabetic patients. Effect of the changes in the diagnostic criteria and stricter control of the diabetes between 1993 and 2005 on the incidence of diabetic retinopathy].
Romero-Aroca P; Fernández-Alart J; Baget-Bernaldiz M; Méndez-Marín I; Salvat-Serra M
Arch Soc Esp Oftalmol; 2007 Apr; 82(4):209-18. PubMed ID: 17443425
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence and risk factors for diabetic retinopathy in type 2 diabetes patients in Jewish and Bedouin populations in southern Israel].
Chorny A; Lifshits T; Kratz A; Levy J; Golfarb D; Zlotnik A; Knyazer B
Harefuah; 2011 Dec; 150(12):906-10, 935. PubMed ID: 22352283
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and it's complications in a Swedish county.
Lundman B; Engström L
Diabetes Res Clin Pract; 1998 Feb; 39(2):157-64. PubMed ID: 9597386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
